Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...
WASHINGTON, DC - SEPTEMBER 30: U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla (L) as he announces a deal with the company to lower Medicaid drug prices and to sell certain ...
Medicare will save approximately $12 billion, or 44%, on 15 high-cost medications as a result of the second round of the program’s drug price negotiations, the Trump administration announced Tuesday ...
Medicare’s newly negotiated prescription drug prices are expected to deliver major savings for older Americans, according to a new analysis from AARP, marking an early milestone in the federal ...